Authors:
GASTER LM
BLANEY FE
DAVIES S
DUCKWORTH DM
HAM P
JENKINS S
JENNINGS AJ
JOINER GF
KING FD
MULHOLLAND KR
WYMAN PA
HAGAN JJ
HATCHER J
JONES BJ
MIDDLEMISS DN
PRICE GW
RILEY G
ROBERTS C
ROUTLEDGE C
SELKIRK J
SLADE PD
Citation: Lm. Gaster et al., THE SELECTIVE 5-HT1B RECEPTOR INVERSE AGONIST TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4'-PIPERIDINE] (SB-224289) POTENTLY BLOCKS TERMINAL 5-HT AUTORECEPTOR FUNCTION BOTH IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 41(8), 1998, pp. 1218-1235
Authors:
BROMIDGE SM
DABBS S
DAVIES DT
DUCKWORTH DM
FORBES IT
HAM P
JONES GE
KING FD
SAUNDERS DV
STARR S
THEWLIS KM
WYMAN PA
BLANEY FE
NAYLOR CB
BAILEY F
BLACKBURN TP
HOLLAND V
KENNETT GA
RILEY GJ
WOOD MD
Citation: Sm. Bromidge et al., NOVEL AND SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS AS POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, AND MOLECULAR MODELING OF SUBSTITUTED 1-(3-PYRIDYLCARBAMOYL)INDOLINES/, Journal of medicinal chemistry, 41(10), 1998, pp. 1598-1612
Citation: Se. Gibson et al., CHIRAL BASE-MEDIATED ASYMMETRIC FUNCTIONALIZATION OF TRICARBONYLCHROMIUM(0) COMPLEXES OF BENZYL SULFIDES, Journal of the Chemical Society. Perkin transactions. I, (15), 1997, pp. 2161-2162
Authors:
BROMIDGE SM
DUCKWORTH M
FORBES IT
HAM P
KING FD
THEWLIS KM
BLANEY FE
NAYLOR CB
BLACKBURN TP
KENNETT GA
WOOD MD
CLARKE SE
Citation: Sm. Bromidge et al., ETHYL-3-PYRIDYL)OXY]-5-PYRIDYL]CARBAMOYL]-INDOLINE (SB-242084) - THE FIRST SELECTIVE AND BRAIN PENETRANT 5-HT2C RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 40(22), 1997, pp. 3494-3496
Authors:
FORBES IT
DABBS S
DUCKWORTH DM
HAM P
JONES GE
KING FD
SAUNDERS DV
BLANEY FE
NAYLOR CB
BAXTER GS
BLACKBURN TP
KENNETT GA
WOOD MD
Citation: It. Forbes et al., SYNTHESIS, BIOLOGICAL-ACTIVITY, AND MOLECULAR MODELING STUDIES OF SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS/, Journal of medicinal chemistry, 39(25), 1996, pp. 4966-4977
Authors:
KENNETT GA
WOOD MD
BRIGHT F
CILIA J
PIPER DC
GAGER T
THOMAS D
BAXTER GS
FORBES IT
HAM P
BLACKBURN TP
Citation: Ga. Kennett et al., IN-VITRO AND IN-VIVO PROFILE OF SB-206553, A POTENT 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE PROPERTIES/, British Journal of Pharmacology, 117(3), 1996, pp. 427-434
Authors:
FORBES IT
HAM P
BOOTH DH
MARTIN RT
THOMPSON M
BAXTER GS
BLACKBURN TP
GLEN A
KENNETT GA
WOOD MD
Citation: It. Forbes et al., LCARBAMOYL)-1,2,3,5-TETRAHYDROPYRROLO[2,3-F]INDOLE - A NOVEL 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH IMPROVED AFFINITY, SELECTIVITY, AND ORAL ACTIVITY, Journal of medicinal chemistry, 38(14), 1995, pp. 2524-2530
Authors:
SMITH SA
ALBARAZANJI KA
BUCKINGHAM RE
CASSIDY F
COLDWELL MC
FINNEY FJL
HADLEY MS
HAM P
LAWRENCE SA
NASH DJ
TINGLEY EJR
WATSON JM
Citation: Sa. Smith et al., THE IDENTIFICATION OF A NOVEL RENIN INHIBITOR OF EQUIVALENT EFFICACY FOLLOWING ORAL OR INTRAVENOUS ADMINISTRATION, Bioorganic & medicinal chemistry letters, 4(11), 1994, pp. 1291-1296
Authors:
FORBES IT
KENNETT GA
GADRE A
HAM P
HAYWARD CJ
MARTIN RT
THOMPSON M
WOOD MD
BAXTER GS
GLEN A
MURPHY OE
STEWART BA
BLACKBURN TP
Citation: It. Forbes et al., N-(1-METHYL-5-INDOLYL)-N'-(3-PYRIDYL)UREA HYDROCHLORIDE - THE 1ST SELECTIVE 5-HT(1C) RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 36(8), 1993, pp. 1104-1107